Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.17 $1.66 Friday, 10th May 2024 IFRX stock ended at $1.18. This is 1.67% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 6.41% from a day low at $1.17 to a day high of $1.25.
90 days $1.17 $1.92
52 weeks $1.14 $5.20

Historical InflaRx N.V. prices

Date Open High Low Close Volume
Nov 22, 2017 $15.00 $15.03 $15.00 $15.00 2 879
Nov 21, 2017 $15.00 $15.15 $14.96 $15.00 30 071
Nov 20, 2017 $14.72 $15.00 $14.53 $14.55 21 840
Nov 17, 2017 $15.15 $15.15 $14.58 $14.83 16 789
Nov 16, 2017 $14.80 $15.20 $14.80 $14.80 17 502
Nov 15, 2017 $14.69 $14.91 $14.55 $14.85 16 403
Nov 14, 2017 $15.14 $15.14 $14.64 $14.66 36 751
Nov 13, 2017 $14.90 $15.09 $14.47 $14.85 106 045
Nov 10, 2017 $15.01 $15.01 $14.62 $15.00 195 094
Nov 09, 2017 $14.89 $15.41 $14.54 $15.00 184 995
Nov 08, 2017 $15.19 $15.48 $14.80 $14.99 1 873 997
Nov 07, 2017 $15.00 $15.00 $15.00 $15.00 100
Click to get the best stock tips daily for free!

About InflaRx N.V.

InflaRx N.V. InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III c... IFRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT